ANA
FERNANDEZ SANTANDER
CATEDRÁTICO
University of Manchester
Mánchester, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Manchester (2)
2013
-
Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen
Personalized Medicine, Vol. 10, Núm. 6, pp. 601-611
2011
-
The clinical effectiveness and costeffectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: A systematic review
Health Technology Assessment, Vol. 15, Núm. 33, pp. 1-102